Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) was $21.97 for the day, down -1.83% from the previous closing price of $22.38. In other words, the price has decreased by -$1.83 from its previous closing price. On the day, 0.84 million shares were traded. SNDX stock price reached its highest trading level at $22.9096 during the session, while it also had its lowest trading level at $21.87.
Ratios:
Our analysis of SNDX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.93 and its Current Ratio is at 8.93. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Scotiabank on January 31, 2024, Downgraded its rating to Sector Perform and sets its target price to $23 from $36 previously.
On December 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $45.
On October 25, 2023, BofA Securities started tracking the stock assigning a Buy rating and target price of $29.BofA Securities initiated its Buy rating on October 25, 2023, with a $29 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 09 ’23 when Morrison Briggs sold 52,855 shares for $18.27 per share. The transaction valued at 965,402 led to the insider holds 17,836 shares of the business.
Meury William sold 83,000 shares of SNDX for $1,697,810 on Aug 02 ’23. The Director now owns 48,000 shares after completing the transaction at $20.46 per share. On Jul 10 ’23, another insider, Morrison Briggs, who serves as the Director of the company, sold 52,855 shares for $20.40 each. As a result, the insider received 1,078,068 and left with 17,836 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNDX now has a Market Capitalization of 1867166592 and an Enterprise Value of 1393552000.
Stock Price History:
Over the past 52 weeks, SNDX has reached a high of $25.34, while it has fallen to a 52-week low of $11.22. The 50-Day Moving Average of the stock is -2.24%, while the 200-Day Moving Average is calculated to be 15.03%.
Shares Statistics:
SNDX traded an average of 1.08M shares per day over the past three months and 950170 shares per day over the past ten days. A total of 84.83M shares are outstanding, with a floating share count of 80.57M. Insiders hold about 5.17% of the company’s shares, while institutions hold 100.95% stake in the company. Shares short for SNDX as of 1713139200 were 9603385 with a Short Ratio of 8.91, compared to 1710460800 on 8329324. Therefore, it implies a Short% of Shares Outstanding of 9603385 and a Short% of Float of 11.3900006.
